A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency

Abroad (travel likely)RecruitingPHASE1

Conditions

Alpha 1-Antitrypsin Deficiency

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Florida, Gainesville, Gainesville, Florida, United States

    Contact: Study coordinator (Allison Faunce) · Allison.Faunce@medicine.ufl.edu · 352-273-8666
    Contact: Principal Investigator (Jorge Lascano, MD)
  • Medical University of South Carolina, Charleston, South Carolina, United States

    Contact: Study coordinator (Charlton Strange, MD)
    Contact: Principal Investigator (Charlton Strange, MD)
  • Renovatio Clinical, The Woodlands, Texas, United States

    Contact: Study coordinator (Dustyn Tobin) · dustyn.tobin@renovatioclinical.com · 713-703-2398
    Contact: Principal Investigator (Ather J Siddiqi, MD)
Study leads
  • David Sweet, MD, PhD

    Study Director

    Director of Clinical Development